Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-02-11 @ 9:11 PM
Study NCT ID:
NCT00683904
Status:
COMPLETED
Last Update Posted:
2016-03-10
First Post:
2008-05-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer
Sponsor:
R-Pharm
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA163-160
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Study Director
Old Organization:
Bristol-Myers Squibb